linderalactone and Ovarian-Neoplasms

linderalactone has been researched along with Ovarian-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for linderalactone and Ovarian-Neoplasms

Article	Year
Isolinderalactone Induces Cell Death via Mitochondrial Superoxide- and STAT3-Mediated Pathways in Human Ovarian Cancer Cells. International journal of molecular sciences, 2020, Oct-13, Volume: 21, Issue:20 The mortality rate of ovarian cancer (OC) worldwide increases with age. OC is an often fatal cancer with a curative rate of only 20-30%, as symptoms often appear after disease progression. Studies have reported that isolinderalactone (ILL), a furanosesquiterpene derivative extracted from the dried root of Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Female; Humans; Janus Kinases; Mitochondria; Ovarian Neoplasms; Sesquiterpenes; STAT3 Transcription Factor; Superoxide Dismutase; Superoxides	2020

Article

Year

Isolinderalactone Induces Cell Death via Mitochondrial Superoxide- and STAT3-Mediated Pathways in Human Ovarian Cancer Cells.

International journal of molecular sciences, 2020, Oct-13, Volume: 21, Issue:20

The mortality rate of ovarian cancer (OC) worldwide increases with age. OC is an often fatal cancer with a curative rate of only 20-30%, as symptoms often appear after disease progression. Studies have reported that isolinderalactone (ILL), a furanosesquiterpene derivative extracted from the dried root of

Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Female; Humans; Janus Kinases; Mitochondria; Ovarian Neoplasms; Sesquiterpenes; STAT3 Transcription Factor; Superoxide Dismutase; Superoxides

2020